Literature DB >> 26844756

Keloids: The paradigm of skin fibrosis - Pathomechanisms and treatment.

Jonathan P Andrews1, Jaana Marttala1, Edward Macarak2, Joel Rosenbloom2, Jouni Uitto3.   

Abstract

Keloids, fibroproliferative dermal tumors with effusive accumulation of extracellular matrix (ECM) components, particularly collagen, result from excessive expression of growth factors and cytokines. The etiology of keloids is unknown but they occur after dermal injury in genetically susceptible individuals, and they cause both physical and psychological distress for the affected individuals. Several treatment methods for keloids exist, including the combination therapy of surgical excision followed by intralesional steroid therapy, however, they have high recurrence rate regardless of the current treatment method. Improved understanding of the pathomechanisms leading to keloid formation will hopefully identify pathways that serve as specific targets to improve therapy for this devastating, currently intractable, disorder.
Copyright © 2016 International Society of Matrix Biology. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Collagen; Fibrotic disease; Inflammation; Keloid; TGF-β; Wound healing

Mesh:

Substances:

Year:  2016        PMID: 26844756      PMCID: PMC4842154          DOI: 10.1016/j.matbio.2016.01.013

Source DB:  PubMed          Journal:  Matrix Biol        ISSN: 0945-053X            Impact factor:   11.583


  94 in total

1.  Keratinocytes promote proliferation and inhibit apoptosis of the underlying fibroblasts: an important role in the pathogenesis of keloid.

Authors:  Emi Funayama; Thinle Chodon; Akihiko Oyama; Tsuneki Sugihara
Journal:  J Invest Dermatol       Date:  2003-12       Impact factor: 8.551

2.  The α4β1 integrin and the EDA domain of fibronectin regulate a profibrotic phenotype in dermal fibroblasts.

Authors:  Arti V Shinde; Rhiannon Kelsh; John H Peters; Kiyotoshi Sekiguchi; Livingston Van De Water; Paula J McKeown-Longo
Journal:  Matrix Biol       Date:  2014-11-26       Impact factor: 11.583

3.  Keloids.

Authors:  B Berman; H C Bieley
Journal:  J Am Acad Dermatol       Date:  1995-07       Impact factor: 11.527

4.  Partial primary structure of bovine plasma fibronectin: three types of internal homology.

Authors:  T E Petersen; H C Thøgersen; K Skorstengaard; K Vibe-Pedersen; P Sahl; L Sottrup-Jensen; S Magnusson
Journal:  Proc Natl Acad Sci U S A       Date:  1983-01       Impact factor: 11.205

5.  Extra domain A of fibronectin primes leukotriene biosynthesis and stimulates neutrophil migration through activation of Toll-like receptor 4.

Authors:  Julie S Lefebvre; Tania Lévesque; Serge Picard; Guillaume Paré; Annie Gravel; Louis Flamand; Pierre Borgeat
Journal:  Arthritis Rheum       Date:  2011-06

6.  Treatment of keloid scars post-shave excision with imiquimod 5% cream: A prospective, double-blind, placebo-controlled pilot study.

Authors:  Brian Berman; Catherine Harrison-Balestra; Oliver A Perez; Martha Viera; Adriana Villa; Deborah Zell; Claudia Ramirez
Journal:  J Drugs Dermatol       Date:  2009-05       Impact factor: 2.114

7.  Keloid fibroblasts exhibit an altered response to TGF-beta.

Authors:  M Babu; R Diegelmann; N Oliver
Journal:  J Invest Dermatol       Date:  1992-11       Impact factor: 8.551

8.  Proline analogues inhibit human skin fibroblast growth and collagen production in culture.

Authors:  E M Tan; L Ryhänen; J Uitto
Journal:  J Invest Dermatol       Date:  1983-04       Impact factor: 8.551

9.  Chemokine and chemokine receptor expression in keloid and normal fibroblasts.

Authors:  C S Nirodi; R Devalaraja; L B Nanney; S Arrindell; S Russell; J Trupin; A Richmond
Journal:  Wound Repair Regen       Date:  2000 Sep-Oct       Impact factor: 3.617

Review 10.  Fibrosis in connective tissue disease: the role of the myofibroblast and fibroblast-epithelial cell interactions.

Authors:  Thomas Krieg; David Abraham; Robert Lafyatis
Journal:  Arthritis Res Ther       Date:  2007       Impact factor: 5.156

View more
  67 in total

Review 1.  The Northwestern Abdominoplasty Scar Model: A Tool for High-Throughput Assessment of Scar Therapeutics.

Authors:  Ji-Cheng Hsieh; Chitang J Joshi; Rou Wan; Robert D Galiano
Journal:  Adv Wound Care (New Rochelle)       Date:  2020-04-29       Impact factor: 4.730

Review 2.  Integrin-mediated regulation of epidermal wound functions.

Authors:  C Michael DiPersio; Rui Zheng; James Kenney; Livingston Van De Water
Journal:  Cell Tissue Res       Date:  2016-06-28       Impact factor: 5.249

3.  Long non-coding RNA HOXA11-AS accelerates the progression of keloid formation via miR-124-3p/TGFβR1 axis.

Authors:  Jun Jin; Zhen-Hua Jia; Xiao-Hua Luo; Hong-Feng Zhai
Journal:  Cell Cycle       Date:  2019-12-27       Impact factor: 4.534

4.  Pathological changes in basement membranes and dermal connective tissue of skin from patients with hereditary cystatin C amyloid angiopathy.

Authors:  Asbjorg Osk Snorradottir; Helgi J Isaksson; Saevar Ingthorsson; Elias Olafsson; Astridur Palsdottir; Birkir Thor Bragason
Journal:  Lab Invest       Date:  2017-01-09       Impact factor: 5.662

5.  The integrative regulatory network of circRNA and microRNA in keloid scarring.

Authors:  Jingpei Shi; Shuluan Yao; Pan Chen; Yuan Yang; Mengjiao Qian; Yi Han; Nan Wang; Yu Zhao; Yongjing He; Lechun Lyu; Di Lu
Journal:  Mol Biol Rep       Date:  2019-10-14       Impact factor: 2.316

6.  CD44 inhibits α-SMA gene expression via a novel G-actin/MRTF-mediated pathway that intersects with TGFβR/p38MAPK signaling in murine skin fibroblasts.

Authors:  Yan Wang; Judith A Mack; Edward V Maytin
Journal:  J Biol Chem       Date:  2019-07-08       Impact factor: 5.157

7.  Adenosine A2A receptor promotes collagen type III synthesis via β-catenin activation in human dermal fibroblasts.

Authors:  Gibran Shaikh; Jin Zhang; Miguel Perez-Aso; Aranzazu Mediero; Bruce Cronstein
Journal:  Br J Pharmacol       Date:  2016-10-04       Impact factor: 8.739

8.  Comparison of Intralesional Triamcinolone Acetonide, 5-Fluorouracil, and Their Combination for the Treatment of Keloids.

Authors:  Sunil Srivastava; Aditya Nanasaheb Patil; Chaitra Prakash; Hiranmayi Kumari
Journal:  Adv Wound Care (New Rochelle)       Date:  2017-11-01       Impact factor: 4.730

Review 9.  MicroRNA-21 in Skin Fibrosis: Potential for Diagnosis and Treatment.

Authors:  Yan Li; Juan Zhang; Yuying Lei; Lechun Lyu; Ruiling Zuo; Ting Chen
Journal:  Mol Diagn Ther       Date:  2017-12       Impact factor: 4.074

Review 10.  Engineered Biomaterial Platforms to Study Fibrosis.

Authors:  Matthew D Davidson; Jason A Burdick; Rebecca G Wells
Journal:  Adv Healthc Mater       Date:  2020-03-17       Impact factor: 9.933

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.